Literature DB >> 12716843

Increased oxidative stress is associated with elevated plasma levels of adrenomedullin in hypertensive patients with type 2 diabetes.

Akira Katsuki, Yasuhiro Sumida, Hideki Urakawa, Esteban C Gabazza, Noriko Maruyama, Kohei Morioka, Nagako Kitagawa, Yasuko Hori, Kaname Nakatani, Yutaka Yano, Yukihiko Adachi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12716843     DOI: 10.2337/diacare.26.5.1642

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  5 in total

1.  Associations of the vasoactive peptides CT-proET-1 and MR-proADM with incident type 2 diabetes: results from the BiomarCaRE Consortium.

Authors:  Chaterina Sujana; Veikko Salomaa; Frank Kee; Jochen Seissler; Pekka Jousilahti; Charlotte Neville; Cornelia Then; Wolfgang Koenig; Kari Kuulasmaa; Jaakko Reinikainen; Stefan Blankenberg; Tanja Zeller; Christian Herder; Ulrich Mansmann; Annette Peters; Barbara Thorand
Journal:  Cardiovasc Diabetol       Date:  2022-06-09       Impact factor: 8.949

Review 2.  Adrenomedullin and diabetes.

Authors:  Hoi Kin Wong; Fai Tang; Tsang Tommy Cheung; Bernard Man Yung Cheung
Journal:  World J Diabetes       Date:  2014-06-15

3.  Plasma adrenomedullin level in Egyptian children and adolescents with type 1 diabetes mellitus: relationship to microvascular complications.

Authors:  Safinaz A El-Habashy; Randa M Matter; Eman S El-Hadidi; Hala R Afifi
Journal:  Diabetol Metab Syndr       Date:  2010-02-10       Impact factor: 3.320

4.  The role of adrenomedullin in the renal NADPH oxidase and (pro)renin in diabetic mice.

Authors:  Michio Hayashi; Akihiro Tojo; Tatsuo Shimosawa; Toshiro Fujita
Journal:  J Diabetes Res       Date:  2013-07-15       Impact factor: 4.011

5.  Adrenomedullin has a cytoprotective role against endoplasmic reticulum stress for pancreatic β-cells in autocrine and paracrine manners.

Authors:  Risa Suetomi; Yasuharu Ohta; Masaru Akiyama; Takuro Matsumura; Akihiko Taguchi; Kaoru Yamamoto; Takashi Kamatani; Yukio Tanizawa
Journal:  J Diabetes Investig       Date:  2020-03-10       Impact factor: 4.232

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.